227 related articles for article (PubMed ID: 32466294)
1. Transcriptomic Response of Breast Cancer Cells MDA-MB-231 to Docosahexaenoic Acid: Downregulation of Lipid and Cholesterol Metabolism Genes and Upregulation of Genes of the Pro-Apoptotic ER-Stress Pathway.
Chénais B; Cornec M; Dumont S; Marchand J; Blanckaert V
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32466294
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid monoglyceride induces apoptosis and autophagy in breast cancer cells via lipid peroxidation-mediated endoplasmic reticulum stress.
Wang TT; Yang Y; Wang F; Yang WG; Zhang JJ; Zou ZQ
J Food Sci; 2021 Oct; 86(10):4704-4716. PubMed ID: 34494660
[TBL] [Abstract][Full Text] [Related]
4. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1.
Blanckaert V; Kerviel V; Lépinay A; Joubert-Durigneux V; Hondermarck H; Chénais B
Int J Oncol; 2015; 46(6):2649-55. PubMed ID: 25825023
[TBL] [Abstract][Full Text] [Related]
7. DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines.
Fasano E; Serini S; Piccioni E; Toesca A; Monego G; Cittadini AR; Ranelletti FO; Calviello G
Biochim Biophys Acta; 2012 Nov; 1822(11):1762-72. PubMed ID: 22898250
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.
Xiong A; Yu W; Tiwary R; Sanders BG; Kline K
Mol Nutr Food Res; 2012 Jun; 56(6):923-34. PubMed ID: 22707267
[TBL] [Abstract][Full Text] [Related]
9. [Effects of docosahexaenoic acid on cell apoptosis, invasion and migration of cervical cancer cells in vitro].
Yang C; Zhang GP; Chen YN; Meng FL; Liu SS; Gong SP
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):848-56. PubMed ID: 27320891
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.
Lee EJ; Yun UJ; Koo KH; Sung JY; Shim J; Ye SK; Hong KM; Kim YN
Biochim Biophys Acta; 2014 Jan; 1841(1):190-203. PubMed ID: 24120917
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells.
Stulnig G; Frisch MT; Crnkovic S; Stiegler P; Sereinigg M; Stacher E; Olschewski H; Olschewski A; Frank S
Atherosclerosis; 2013 Oct; 230(2):406-13. PubMed ID: 24075775
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid differentially modulates the cell cycle and metabolism- related genes in tumor and pre-malignant prostate cells.
Tamarindo GH; Góes RM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158766. PubMed ID: 32712248
[TBL] [Abstract][Full Text] [Related]
15. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid activates some SREBP-2 targets independent of cholesterol and ER stress in SW620 colon cancer cells.
Størvold GL; Fleten KG; Olsen CG; Follestad T; Krokan HE; Schønberg SA
Lipids; 2009 Aug; 44(8):673-83. PubMed ID: 19582494
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells.
Fernando W; Coombs MRP; Hoskin DW; Rupasinghe HPV
Carcinogenesis; 2016 Oct; 37(10):1004-1013. PubMed ID: 27535497
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
[TBL] [Abstract][Full Text] [Related]
19. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response.
Vibet S; Goupille C; Bougnoux P; Steghens JP; Goré J; Mahéo K
Free Radic Biol Med; 2008 Apr; 44(7):1483-91. PubMed ID: 18267129
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
